Brain lesions in HIV: lymphoma or toxoplasmosis
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Someone with advanced HIV develops headaches and confusion. A scan shows lesions in the brain that light up in a ring. Two diagnoses account for most of these, and they could not be more different.
One is an infection cured with antibiotics. The other is a cancer needing chemotherapy. Telling them apart is one of the defining problems of HIV medicine.
Related pages: AIDS-related lymphoma
The bottom line
- Both conditions occur at very low CD4 counts and look similar on scans.
- Toxoplasmosis is more common and responds to specific antibiotics.
- Primary CNS lymphoma in HIV is essentially always EBV-positive.
- EBV DNA in spinal fluid and functional imaging help distinguish them.
- How reliably newer imaging and spinal fluid tests avoid the need for biopsy.
- How best to manage people in whom neither test is conclusive.
The story, step by step
What the evidence labels mean
What they are
What happens
Both occur in advanced HIV, and both present with the brain not working properly.
What the research shows
- Cerebral toxoplasmosis is reactivation of a dormant parasite, Toxoplasma gondii, carried by a large proportion of the world's population, which the immune system normally keeps suppressed.
- Primary CNS lymphoma is an aggressive B-cell lymphoma confined to the brain, spinal cord, their coverings and the eyes.
- Both typically occur with CD4 counts below 100, and lymphoma more often below 50.
- Both present with headache, confusion, personality change, seizures, or weakness on one side, developing over days to weeks.
- Both appear on MRI as lesions that enhance with contrast, often in a ring, with swelling around them.
Why it matters
The symptoms and the scan cannot reliably separate them, which is the whole problem.
What's still uncertain
- Other causes, including tuberculosis, cryptococcoma, abscess and progressive multifocal leukoencephalopathy, also enter the differential.
Read more
- Clinicalinfo (NIH): Guidelines for opportunistic infections in adults with HIVGovernment
- OwieClear: Primary CNS lymphomaOwieClear
Next: Clues
What tips the balance
What happens
Several features shift the probability, though none settles it alone.
What the research shows
- Number of lesions: toxoplasmosis more often produces multiple lesions; lymphoma more often a single one, though both occur either way.
- Location: lymphoma more often sits deep, near the ventricles or crossing the midline; toxoplasmosis favours the basal ganglia and the junction between grey and white matter.
- Toxoplasma antibody status: a negative IgG makes toxoplasmosis much less likely, though not impossible.
- Whether the person has been taking co-trimoxazole, which prevents both Pneumocystis pneumonia and toxoplasmosis. Toxoplasmosis in someone reliably taking it is unusual.
- CD4 count: lymphoma concentrates at the very lowest counts.
Why it matters
A negative toxoplasma antibody test in someone taking co-trimoxazole shifts the odds strongly toward lymphoma.
What's still uncertain
- None of these features is reliable enough on its own to direct treatment.
Read more
Next: The old approach
Treat and see
What happens
For many years the standard approach was an empirical treatment trial, and it is still used in some settings.
What the research shows
- Treat for toxoplasmosis with specific antibiotics and repeat the scan after about two weeks.
- Toxoplasmosis usually improves clinically and radiologically within that time. Lymphoma does not.
- Failure to respond was taken as evidence for lymphoma, prompting biopsy or treatment.
- The cost is two weeks during which an aggressive lymphoma grows untreated, and brain biopsy is not a trivial procedure.
- This approach is reasonable where advanced imaging and specialized spinal fluid testing are not available, and it remains common worldwide.
Why it matters
Two weeks is a long time in an aggressive brain lymphoma, which is why better tests mattered so much.
What's still uncertain
- Partial responses are common and make interpretation difficult.
Read more
Next: Better tests
EBV in the spinal fluid, and functional imaging
What happens
Two developments reduced the need for empirical trials.
What the research shows
- EBV DNA measured by PCR in the cerebrospinal fluid: HIV-associated primary CNS lymphoma is essentially always EBV-driven, so finding EBV DNA in the fluid strongly supports it.
- The test performs best when combined with imaging; a positive result in the right clinical setting can be close to diagnostic.
- Functional imaging, with PET or thallium SPECT, distinguishes metabolically active tumour from infection. Lymphoma takes up tracer avidly; toxoplasmosis generally does not.
- Spinal fluid cytology and flow cytometry can find lymphoma cells directly, though sensitivity is limited.
- Combining EBV PCR with functional imaging avoids biopsy in many cases.
Why it matters
Asking whether EBV PCR on spinal fluid has been sent is a reasonable and specific question in this situation.
What's still uncertain
- Lumbar puncture may be unsafe if there is significant pressure or swelling, which must be assessed first.
Read more
- NCI: Primary CNS lymphoma treatmentGovernment
- Clinicalinfo (NIH): Guidelines for opportunistic infections in adults with HIVGovernment
Next: Treatment
Why this is no longer hopeless
What happens
Primary CNS lymphoma in HIV had a dismal reputation that is now out of date.
What the research shows
- It is treated with high-dose methotrexate-based chemotherapy, given with antiretroviral therapy.
- Restoring immune control of EBV is part of the treatment rather than a separate matter, which is why starting or optimizing HIV treatment is urgent.
- Whole-brain radiotherapy, once standard, is now generally deferred or avoided because of long-term cognitive effects, particularly in people who may live for many years afterwards.
- Outcomes improved substantially in the antiretroviral era, from a condition measured in weeks to one where long-term survival is possible.
- Toxoplasmosis, if that is the answer, is treated with antibiotics followed by maintenance treatment until the CD4 count recovers.
Why it matters
The outlook for both of these is far better than older material suggests, and in both cases effective HIV treatment is central.
What's still uncertain
- Treatment of CNS lymphoma is complex and belongs at a centre with relevant experience.